SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.
Oddsmakers are expecting another big season from the Celtics. The post What oddsmakers are projecting for Celtics, top ...
Vontobel Holding Ltd. lowered its holdings in shares of Analog Devices, Inc. (NASDAQ:ADI – Free Report) by 1.8% in the 3rd ...
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...
Europe’s answer to the Magnificent Seven is leaving much to be desired after two of the Continent’s biggest companies, ASML ...
Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...